USFDA nod to t:connect, first app for insulin delivery
The app displays pump alerts and alarms, and it securely uploads data into the cloud-based t: connect web application wirelessly.
Advertisement
New Delhi: The US Food and Drug Administration (FDA) has cleared the first smartphone app for insulin delivery on both iOS and Android operating systems.
The move is seen as a big relief for people who prefer not to have insulin pumps out in public settings or attach them to undergarments like bras.
Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, announced that FDA has cleared 'bolus insulin' dosing on the 't:slim X2' insulin pump using the 't:connect' mobile app.
Read also: Lupin Solosec gets USFDA nod to treat trichomoniasis, bacterial vaginosis in adolscents
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.